Although the underlying molecular mechanisms of the altered neurogenesis in PD remain unknown, neurochemical deficits of dopamine (Mishra et al., 2019b), indirect effects of growth factor release, and α-synuclein accumulation in NPCs of the SVZ via the disease process may influence neurogenic activity (Winner et al., 2012). This evidence concerns the gene SNCA and Parkinson disease.